Affordable Access

Publisher Website

Surface microdialysis measures local tissue metabolism after Ivor Lewis esophagectomy; an attempt to predict anastomotic defect.

  • Åkesson, Oscar1
  • Abrahamsson, Pernilla2
  • Johansson, Göran2
  • Haney, Michael2
  • Falkenback, Dan1
  • Hermansson, Michael1
  • Jeremiasen, Martin1
  • Johansson, Jan1
  • 1 Department of Surgery, Skåne University Hospital and Department of Clinical Sciences, Lund University, Lund, Sweden. , (Sweden)
  • 2 Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden. , (Sweden)
Published Article
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Publication Date
Jul 27, 2023
DOI: 10.1093/dote/doac111
PMID: 36572400


Anastomotic defect (AD) after esophagectomy can lead to severe complications with need for surgical or endoscopic intervention. Early detection enables early treatment and can limit the consequences of the AD. As of today, there are limited methods to predict AD. In this study, we have used microdialysis (MD) to measure local metabolism at the intrathoracic anastomosis. Feasibility and possible diagnostic use were investigated. Sixty patients planned for Ivor Lewis esophagectomy were enrolled. After construction of the anastomosis, surface MD (S-MD) probes were attached to the outer surface of the esophageal remnant and the gastric conduit in close vicinity of the anastomosis and left in place for 7 postoperative days (PODs). Continuous sampling of local tissue concentrations of metabolic substances (glucose, lactate, and pyruvate) was performed postoperatively. Outcome, defined as AD or not according to Esophagectomy Complications Consensus Group definitions, was recorded at discharge or at first postoperative follow up. Difference in concentrations of metabolic substances was analyzed retrospectively between the two groups by means of artificial neural network technique. S-MD probes can be attached and removed from the gastric tube reconstruction without any adverse events. Deviating metabolite concentrations on POD 1 were associated with later development of AD. In subjects who developed AD, no difference in metabolic concentrations between the esophageal and the gastric probe was recorded. The technical failure rate of the MD probes/procedure was high. S-MD can be used in a clinical setting after Ivor Lewis esophagectomy. Deviation in local tissue metabolism on POD 1 seems to be associated with development of AD. Further development of MD probes and procedure is required to reduce technical failure. © The Author(s) 2022. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: [email protected].

Report this publication


Seen <100 times